TScan Therapeutics, Inc.

TCRX · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$178,689$133,359$120,027$161,405
Short-Term Investments$111,421$58,685$0$0
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$2,612$2,193$4,100$4,249
Total Curr. Assets$292,722$194,237$124,127$165,654
Property Plant & Equip (Net)$71,599$71,234$69,202$17,256
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$5,037$5,197
Tax Assets$0$0$0$0
Other NC Assets$6,797$6,678$725$0
Total NC Assets$78,396$77,912$74,964$22,453
Other Assets$0$0$0$0
Total Assets$371,118$272,149$199,091$188,107
Liabilities
Payables$4,278$2,374$2,912$1,765
Short-Term Debt$4,570$6,593$3,681$1,651
Tax Payable$0$0$0$0
Deferred Revenue$11,698$10,137$3,874$11,410
Other Curr. Liab.$15,410$10,716$6,838$6,517
Total Curr. Liab.$35,956$29,820$17,305$21,343
LT Debt$92,811$85,840$82,303$4,392
Deferred Rev, NC$1,246$5,622$0$1,497
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$135$0$49$97
Total NC Liab.$94,192$91,462$82,352$5,986
Other Liabilities$0$0$0$0
Cap. Leases$65,309$62,386$53,013$4,392
Total Liabilities$130,148$121,282$99,657$27,329
Equity
Pref Stock$0$0$0$0
Common Stock$6$5$3$3
Retained Earnings-$375,096-$247,597-$158,379-$92,158
AOCI$51$0$0$0
Other Equity$616,009$398,459$257,810$252,933
Total Equity$240,970$150,867$99,434$160,778
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$371,118$272,149$199,091$188,107
Net Debt-$81,308-$40,926-$34,043-$155,362